S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
Important info on NVDA trade (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions

Baker Hughes (BKR) Stock Forecast & Price Target

$33.97
+0.08 (+0.24%)
(As of 11/27/2023 ET)
Compare
Today's Range
$33.49
$34.05
50-Day Range
$33.14
$36.59
52-Week Range
$26.12
$37.58
Volume
4.43 million shs
Average Volume
6.87 million shs
Market Capitalization
$34.18 billion
P/E Ratio
20.46
Dividend Yield
2.36%
Price Target
$39.56

Baker Hughes Consensus Analyst Rating and Stock Price Forecast (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 15 Analyst Ratings

Analysts' Consensus Price Target

$39.56
16.46% Upside
High Forecast$47.00
Average Forecast$39.56
Low Forecast$32.00
TypeCurrent Forecast
11/28/22 to 11/28/23
1 Month Ago
10/29/22 to 10/29/23
3 Months Ago
8/30/22 to 8/30/23
1 Year Ago
11/28/21 to 11/28/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$39.56$39.56$38.22$34.54
Predicted Upside16.46% Upside17.12% Upside19.54% Upside25.38% Upside
Get Baker Hughes Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BKR and its competitors with MarketBeat's FREE daily newsletter.


BKR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BKR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Baker Hughes Stock vs. The Competition

TypeBaker HughesOils/Energy CompaniesS&P 500
Consensus Rating Score
2.87
2.56
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside16.46% Upside413.80% Upside5,661.31% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/27/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$42.00 ➝ $43.00+22.79%
10/17/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$37.00 ➝ $40.00+12.04%
10/3/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$37.00 ➝ $36.00+4.17%
10/2/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$42.00 ➝ $44.00+27.28%
9/11/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$43.00 ➝ $47.00+26.34%
8/17/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$34.00 ➝ $37.00+5.80%
7/25/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$40.00 ➝ $42.00+17.85%
7/24/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$38.00 ➝ $40.00+11.83%
7/21/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$40.00 ➝ $43.00+24.06%
7/20/2023Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive$38.00 ➝ $42.00+19.32%
7/20/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$37.00 ➝ $39.00+10.80%
6/7/2023Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Becker
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$38.00+23.42%
4/20/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$37.00 ➝ $38.00+24.35%
3/15/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$32.00+12.83%
2/2/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$33.00 ➝ $36.00+12.57%
1/19/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$36.00+17.30%
(Data available from 11/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BKR Price Target - Frequently Asked Questions

What is Baker Hughes's consensus rating and price target?

According to the issued ratings of 15 analysts in the last year, the consensus rating for Baker Hughes stock is Moderate Buy based on the current 2 hold ratings and 13 buy ratings for BKR. The average twelve-month price prediction for Baker Hughes is $39.56 with a high price target of $47.00 and a low price target of $32.00. Learn more on BKR's analyst rating history.

Do Wall Street analysts like Baker Hughes more than its competitors?

Analysts like Baker Hughes more than other Oils/Energy companies. The consensus rating score for Baker Hughes is 2.87 while the average consensus rating score for oils/energy companies is 2.56. Learn more on how BKR compares to other companies.

Does Baker Hughes's stock price have much upside?

According to analysts, Baker Hughes's stock has a predicted upside of 17.12% based on their 12-month stock forecasts.

What analysts cover Baker Hughes?

Baker Hughes has been rated by Barclays, Jefferies Financial Group, Morgan Stanley, Piper Sandler, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:BKR) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -